5 Papers
3 Citations
Sacha Wolf is an academic researcher from Johns Hopkins University School of Medicine. The author has contributed to research in topics: Prostate biopsy & Prostate cancer. The author has an hindex of 3, co-authored 5 publications.
Chat about Author
Papers
Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer.
Jeffrey J. Tosoian,Mufaddal Mamawala,Jonathan I. Epstein,Patricia Landis,Sacha Wolf,Bruce J. Trock,H. Ballentine Carter +6 more
TL;DR: Men with favorable-risk prostate cancer should be informed of the low likelihood of harm from their diagnosis and should be encouraged to consider surveillance rather than curative intervention.
547
Elevated Prostate Health Index (phi) and Biopsy Reclassification During Active Surveillance of Prostate Cancer
Darian Andreas,Jeffrey J. Tosoian,Patricia Landis,Sacha Wolf,Stephanie Glavaris,Tamara L. Lotan,Edward M. Schaeffer,Lori J. Sokoll,Ashley E. Ross +8 more
TL;DR: A case is described in which an elevated phi encouraged biopsy of a gentleman undergoing active surveillance leading to reclassification of his disease as high risk prostate cancer.
2
Longitudinal assessment of urinary PCA3 for predicting prostate cancer grade reclassification in favorable-risk men during active surveillance
Jeffrey J. Tosoian,Hiten D. Patel,Mufaddal Mamawala,Patricia Landis,Sacha Wolf,Debra J. Elliott,Jonathan I. Epstein,H.B. Carter,Ashley E. Ross,Lori J. Sokoll,Christian P. Pavlovich +10 more
TL;DR: PCA3 was a significant predictor of GR in a multivariable model including conventional risk factors, suggesting that PCA3 provides incremental prognostic information in the AS setting.
The Role of Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Biopsy in Active Surveillance
Ting Martin Ma,Jeffrey J. Tosoian,Edward M. Schaeffer,Patricia Landis,Sacha Wolf,Katarzyna J. Macura,Jonathan I. Epstein,Mufaddal Mamawala,H. Ballentine Carter +8 more
TL;DR: It is suggested that image-guided prostate biopsy alone may not be informative for men enrolled in an active surveillance program for prostate cancer, and SB still needs to be performed for men on AS.